Yarbrough Capital’s Boston Scientific BSX Stock Holding History

Yarbrough Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-38,456	Closed	-$1.64M	–	84
2026 Q2	$1.64M	Hold	38,456	–	–	0.05%	67
2026 Q1	$2.41M	Hold	38,456	–	–	0.08%	63
2025 Q4	$3.67M	Hold	38,456	–	–	0.11%	62
2025 Q3	$3.75M	Hold	38,456	–	–	0.12%	68
2025 Q2	$4.13M	Hold	38,456	–	–	0.15%	57
2025 Q1	$3.88M	Hold	38,456	–	–	0.17%	57
2024 Q4	$3.43M	Hold	38,456	–	–	0.13%	61
2024 Q3	$3.22M	Hold	38,456	–	–	0.13%	63
2024 Q2	$2.96M	Hold	38,456	–	–	0.12%	61
2024 Q1	$2.63M	Hold	38,456	–	–	0.11%	68
2023 Q4	$2.22M	Hold	38,456	–	–	0.12%	71
2023 Q3	$2.03M	Hold	38,456	–	–	0.12%	73
2023 Q2	$2.08M	Hold	38,456	–	–	0.12%	71
2023 Q1	$1.92M	Hold	38,456	–	–	0.16%	72
2022 Q4	$1.78M	Hold	38,456	–	–	0.14%	67
2022 Q3	$1.49M	Hold	38,456	–	–	0.12%	76
2022 Q2	$1.43M	Hold	38,456	–	–	0.11%	75
2022 Q1	$1.7M	Hold	38,456	–	–	0.1%	81
2021 Q4	$1.63M	Buy	+38,456	New	+$1.62M	0.09%	95

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Yarbrough Capital's BSX Position: Q3 2026 in Review

Yarbrough Capital sold out of Boston Scientific (BSX) in Q3 2026, closing a stake of 38,456 shares — an estimated $1.64M sold.

Yarbrough Capital first reported a position in BSX in Q4 2021 and held it in 19 quarters. The position peaked at $4.13M in Q2 2025. 521 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Yarbrough Capital reported no remaining Boston Scientific position as of Q3 2026 after selling out during the quarter.
Yarbrough Capital sold 38,456 Boston Scientific shares in Q3 2026, an estimated $1.64M.
Yarbrough Capital first reported a position in Boston Scientific in Q4 2021 and held it in 19 quarters.
Yarbrough Capital's Boston Scientific position peaked at $4.13M in Q2 2025.
521 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Yarbrough Capital's 13F filing for Q3 2026, filed 19 Oct 2026.